Quanterix (QTRX) Misses Q4 EPS by 6c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
March 2, 2026 4:01 PM ESTReports $43.9 million in revenue and cash balance of $122 million
Company expects to achieve cash flow breakeven during 2026
BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the fourth quarter and full year ended December 31, 2025.
I am thrilled to be joining Quanterix at a time when the company is well-positioned to deliver long-term growth, said Everett Cunningham, President & CEO of Quanterix. During the fourth quarter, we exceeded our revenue... More
